Effect of Voluven on postoperative morbidity after gynaecological surgery

Phase 1

• Conditions: Healthy female patients (American Society of Anaesthesiologists score I or II) programmed for elective gynaecological surgery and at least 18 years old; MedDRA version: 8.1Level: LLTClassification code 10054182Term: Perioperative nausea and vomiting prophylaxis

• Registration Number: EUCTR2006-004720-37-BE
• Lead Sponsor: CUB Hôpital Erasme, Department of Anesthesiology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-09-12
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

ASA I or II female patients for elective gynaecological surgery and at least 18 years old
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Allergic reaction to Voluven
Caesarean

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified